Bibliography
- de Fougerolles A , VornlocherHP, MaraganoreJ, LiebermanJ: Interfering with disease: a progress report on siRNA-based therapeutics.Nat. Rev. Drug. Discov.6, 443–453 (2007).
- Kim DH , BehlkeMA, RoseSD, ChangMS, ChoiS, RossiJJ: Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy.Nat. Biotechnol.23, 222–226 (2005).
- Morris KV , ChanSW, JacobsenSE, LooneyDJ: Small interfering RNA-induced transcriptional gene silencing in human cells.Science305, 1289–1292 (2004).
- He L , HannonGJ: MicroRNAs: small RNAs with a big role in gene regulation.Nat. Rev. Genet.5, 522–531 (2004).
- Howard KA : Delivery of RNA interference therapeutics using polycation-based nanoparticles.Adv. Drug Deliv. Rev.61, 710–720 (2009).
- Schiffelers RM , AnsariA, XuJet al.: Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle.Nucleic Acids Res.32, e149 (2004).
- Bartlett DW , DavisME: Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles.Biotechnol. Bioeng.99, 975–985 (2008).
- Kim SH , JeongJH, LeeSH, KimSW, ParkTG: Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer.J. Control. Release129, 107–116 (2008).
- Peer D , ParkEJ, MorishitaY, CarmanCV, ShimaokaM: Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target.Science319, 627–630 (2008).
- Takeshita F , MinakuchiY, NagaharaSet al.: Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.Proc. Natl Acad. Sci. USA102, 12177–12182 (2005).
- Ishimoto T , TakeiY, YuzawaYet al.: Downregulation of monocyte chemoattractant protein-1 involving short interfering RNA attenuates hapten-induced contact hypersensitivity.Mol. Ther.16, 387–395 (2008).
- Baigude H , MccarrollJ, YangCS, SwainPM, RanaTM: Design and creation of new nanomaterials for therapeutic RNAi.ACS Chem. Biol.2, 237–241 (2007).
- Zimmermann TS , LeeAC, AkincAet al.: RNAi-mediated gene silencing in non-human primates.Nature441, 111–114 (2006).
- Thomas M , LuJJ, GeQ, ZhangC, ChenJ, KlibanovAM: Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung.Proc. Natl Acad. Sci. USA102, 5679–5684 (2005).
- Howard KA , RahbekUL, LiuXet al.: RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system.Mol. Ther.14, 476–484 (2006).
- Rahbek UL , HowardKA, OupickyDet al.: Intracellular siRNA and precursor miRNA trafficking using bioresponsive copolypeptides.J. Gene Med.10, 81–93 (2008).
- Robbins M , JudgeA, AmbegiaEet al.: Misinterpreting the therapeutic effects of small interfering RNA caused by immune stimulation.Hum. Gene Ther.19, 991–999 (2008).
- Robbins M , JudgeA, MaclachlanI: siRNA and innate immunity.Oligonucleotides19, 89–102 (2009).
- Howard KA , PaludanSR, BehlkeMA, BesenbacherF, DeleuranB, KjemsJ: Chitosan/siRNA nanoparticle-mediated TNF-α knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model.Mol. Ther.17, 162–168 (2009).
- Judge AD , BolaG, LeeAC, MaclachlanI: Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo.Mol. Ther.13, 494–505 (2006).
- Akhtar S , BenterI: Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.Adv. Drug Deliv. Rev.59, 164–182 (2007).
- Hu-Lieskovan S , HeidelJD, BartlettDW, DavisME, TricheTJ: Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing‘s sarcoma.Cancer Res.65, 8984–8992 (2005).
- Heidel JD , YuZ, LiuJYet al.: Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA.Proc. Natl Acad. Sci. USA104, 5715–5721 (2007).